North America Immunochemistry Market

The North America immunochemistry market is expected to reach US$ 1,536.87 Mn in 2027 from US$ 806.34 Mn in 2018. The market is estimated to grow with a CAGR of 7.6% from 2019-2027.

The growth of the market is driven by the factors such as, rising incidences of chronic and infectious diseases and increasing geriatric population. However, the market is likely to slower down its growth due to the limitations associated with immunohistochemistry.

The countries in the region are creating significant opportunities for the key market players to expand their business. It is likely to be a major factor contributing to the market growth during the coming years. With rising costs of production against their practices, the healthcare companies are striving to produce sufficient revenue to entertain their investors. The markets in some growing economies are expected to be an essential part of offering more reliable and profitable growth opportunities for the major players to expand their industry and geographic scope.

Also, the rising advancements in the biotechnology have increased the demand for diagnostics in the healthcare market, encouraging the introduction of a more significant number of immunoassay systems and facilitating the shift toward personalized medicine. There are new opportunities in infectious disease testing, molecular oncology, and pharmacogenomics in emerging countries. Hence, healthcare companies can target patients or consumers in a developing nation.

There has been an increase in the healthcare expenditure of the countries during the previous years. As per World Bank in the United States, 17.1% of its GDP is committed to the industry, whereas in Latin America, healthcare expenditures account for only 7.24%, with Mexico at 6.3% and Brazil at 8.3%. Thus, the rising number of infectious disease incidences and advancements are likely to boost the market and are anticipated to provide significant growth opportunities to the players operating in the market during the forecast period.

The US is expected to lead the market in the North America region owing to the rapidly increasing incidence of chronic diseases like cancer in the country and the growing demand for diagnostics. Furthermore, the increasing prevalence of diabetes is also likely to grow the market of immunohistochemistry. Therefore, considering the above-mentioned factors, the growth of the market in the country is expected to contribute the largest share in the North America region during the forecast period.

Mexico Immunohistochemistry Market Revenue and Forecasts to 2027 (US$ Mn)

Get more information on this report Request Free Sample PDF

North America Immunochemistry Strategic Insights

Strategic insights for the North America Immunochemistry provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Immunochemistry Report Scope

North America Immunochemistry Regional Insights

The geographic scope of the North America Immunochemistry refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

NORTH AMERICA IMMUNOHISTOCHEMISTRY – MARKET SEGMENTATION

By Product

• Antibodies
  • Primary Antibodies
  • Secondary Antibodies
• Equipment
  • Slide Staining Systems
  • Tissue Microarray Systems
  • Slide Scanners
  • Other Equipment
• Reagents
  • Histological Stains
  • Blocking and Fixation Reagents
  • Chromogenic Substrates
  • Stabilizers
  • Solvents
  • Proteolytic Enzymes
• Kits

By Application

• Diagnostics
  • Cancer
  • Infectious Diseases
  • Autoimmune Diseases
  • Diabetes Mellitus
  • Nephrological Diseases
• Drug Testing

By

End-User

• Hospitals and Diagnostic Laboratories
• Research Institutes
• Others

By Geography

• North America

  • US
  • Canada
  • Mexico

Company Profiles

• PerkinElmer, Inc.
• Abcam Plc
• Agilent Technologies,
• Bio SB
• Bio-Rad Laboratories, Inc.
• Cell Signalling Technology, Inc.
• F. Hoffmann-La Roche Ltd.
• Danaher
• Merck KGaA
• Thermo Fisher Scientific, Inc.